Life Technologies Begins Shipping QuantStudio™ 3D Digital PCR System

     Life Technologies Begins Shipping QuantStudio™ 3D Digital PCR System

Disruptive benchtop system makes digital PCR attainable to any lab

PR Newswire

CARLSBAD, Calif., June 10, 2013

CARLSBAD, Calif., June 10, 2013 /PRNewswire/ -- Life Technologies Corporation
(NASDAQ: LIFE) today announces it has begun commercial shipments of the
QuantStudio™ 3D Digital PCR System, the first chip-based instrument designed
for this rapidly growing segment of the genetic analysis market. Featuring the
simplest workflow and smallest footprint available on the market, the benchtop
platform is designed for experiments requiring absolute quantification of
targeted DNA molecules and disruptively priced at $39,000 to enable broad
accessibility to all laboratories.

Scientists worldwide commonly use real-time PCR (polymerase chain reaction) to
amplify and quantify nucleic acids. A variation of that powerful technology,
digital PCR goes beyond the limits of real-time PCR and provides absolute
quantification of DNA samples, making the application ideally suited for
accurately detecting rare genetic mutations important in cancer or infectious

"Good research depends on three things: researchers' techniques, appropriate
funding and sample quality. Compared to in-situ hybridization methods, digital
PCR has a direct impact on these components," said Bruno Ping, senior
biomedical scientist, Royal Surrey County Hospital in the U.K. "The great
advantage of the QuantStudio 3D is that it makes copy number variation
research, for example, more readily available and cost effective as you are
able to probe a higher number of samples at lower price points. The data
achieved in my lab correlate well with our previous results."

The QuantStudio™ 3D Digital PCR System is designed to be affordable and easy
to use for a wide variety of laboratory settings. The simple workflow,
combined with the system's chip-based approach, reduces the number of required
hands-on steps to begin experiments – reducing the risk of sample
contamination and loss of DNA normally associated with droplet-based systems
on the market. Once a sample has been loaded onto the chip, the system takes
less than one minute to return initial data.

At the heart of the instrument is the high-density, nanofluidic silicon chip
that enables up to 20,000 data points, coverage that satisfies the needs for
most digital PCR applications today. The platform also takes up minimal
footprint on the bench, measuring about 5 inches wide, 8.5 inches long and 8
inches tall. 

The new platform is the latest addition to a growing line of QuantStudio™
digital qPCR instruments from Life Technologies. It complements the
QuantStudio™ 12K Flex Real-Time PCR System, which the company launched in
2012. Once considered a niche market, digital PCR is expected to grow to
nearly $250 million globally by 2016, according to reports from Frost &
Sullivan and DeciBio. Previously, the market was limited by the high cost and
cumbersome workflow associated with prior digital platforms.

"Effective today, we have democratized digital PCR by introducing a novel
instrument and system that simplifies the workflow and enables accessibility
by labs of all sizes around the world," says Chris Linthwaite, Head of Genetic
Analysis, Life Technologies. "The QuantStudio 3D Digital PCR System reflects
our singular focus to develop revolutionary platforms that enable diverse
scientific communities to answer questions across a wide range of industries
and applications."

Life Technologies will host two customer presentations June 10 during the
European Society of Human Genetics (ESHG) conference: Bruno Ping will discuss
the results of his research on Her-2 amplification in breast cancer FFPE
samples using the QuantStudio™ 3D Digital PCR System; and Dr. Erik Springer
will discuss his work on detection of BRAF-V600E mutation by comparing data
from ARMS-PCR and digital PCR. For more information on the talks and all of
Life's activities at the conference, visit the company's ESHG website.

The QuantStudio™ 3D Digital PCR System is for research use only; not for use
in diagnostic procedures.

About Life Technologies
Life Technologies Corporation(NASDAQ:LIFE) is a global biotechnology company
that is committed to providing the most innovative products and services to
leading customers in the fields of scientific research, genetic analysis and
applied sciences. With a presence in more than 180 countries, the company's
portfolio of 50,000 end-to-end solutions is secured by more than 5,000 patents
and licenses that span the entire biological spectrum -- scientific
exploration, molecular diagnostics, 21^stcentury forensics, regenerative
medicine and agricultural research. Life Technologies has approximately 10,000
employees and had sales of $3.8 billion in 2012.

Life Technologies' Safe Harbor Statement
This press release includes forward-looking statements about our anticipated
results that involve risks and uncertainties. Some of the information
contained in this press release, including, but not limited to, statements as
to industry trends and Life Technologies' plans, objectives, expectations and
strategy for its business, contains forward-looking statements that are
subject to risks and uncertainties that could cause actual results or events
to differ materially from those expressed or implied by such forward-looking
statements. Any statements that are not statements of historical fact are
forward-looking statements. When used, the words "believe," "plan," "intend,"
"anticipate," "target," "estimate," "expect" and the like, and/or future tense
or conditional constructions ("will," "may," "could," "should," etc.), or
similar expressions, identify certain of these forward-looking statements.
Important factors which could cause actual results to differ materially from
those in the forward-looking statements are detailed in filings made byLife
Technologies with the Securities and Exchange Commission.Life Technologies
undertakes no obligation to update or revise any such forward-looking
statements to reflect subsequent events or circumstances.


Life Technologies Contact
Mauricio Minotta

SOURCE Life Technologies Corporation

Press spacebar to pause and continue. Press esc to stop.